An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

European Journal of Pharmacology

Volumn 353, Issue 1, 1998, Pages 23-31

  Ben Shabat, Shimon ^a   Fride, Ester ^a   Sheskin, Tzviel ^a   Tamiri, Tsippy ^b   Rhee, Man Hee ^c   Vogel, Zvi ^c   Bisogno, Tiziana ^d   De Petrocellis, Luciano ^e   Di Marzo, Vincenzo ^d   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Div Identification Forensic Sci   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d CNR   (Italy)

^e CNR   (Italy)

Author keywords

2 Arachidonoyl glycerol inactivation; Anandamide; Cannabinoid receptor; Endocannabinoid

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ADENYLATE CYCLASE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; GLYCEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG PURIFICATION; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HYPOTHERMIA; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CELL LINE; COS CELLS; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCERIDES; HYDROLYSIS; HYPOTHERMIA; LIGANDS; MICE; MOTOR ACTIVITY; PAIN MEASUREMENT; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPLEEN;

EID: 0031830516     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00392-6     Document Type: Article

References (21)

1. 9-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J. Biol. Chem. 271, 9902-9905.
2. Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., Di Marzo, V., 1997a. Biosynthesis, uptake and degradation of anandamide and palmitoyl-ethanolamide in leukocytes. J. Biol. Chem. 272, 3315-3323.
3. Bisogno, T., Sepe, N., Melck, D., Maurelli, S., De Petrocellis, L., Di Marzo, V., 1997b. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoyl-glycerol in mouse neuroblastoma cells. Biochem. J. 322, 671-677.
4. Devane, W.A., Breuer, A., Sheskin, T., Järbe, T.U.C., Eisen, M., Mechoulam, R., 1992a. A novel probe for the cannabinoid receptor. J. Med. Chem. 35, 2065-2069.
5. Devane, W.A., Hanuš, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R., 1992b. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
6. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., Piomelli, D., 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
7. Di Marzo, V., Bisogno, T., Sugiura, T., Melck, D., De Petrocellis, L., 1998. The novel endogenous cannabinoid 2-arachidonoyl glycerol is inactivated by neuro and basophil-like cells: connections with anandamide. Biochem. J. 331, 15-19.
8. Di Tomaso, E., Beltramo, M., Piomelli, D., 1996. Brain cannabinoids in chocolate. Nature 382, 677-678.
9. Facci, L., Dal-Toso, R., Romanello, S., Buriani, A., Skaper, S.D., Leon, A., 1995. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92, 3376-3380.
10. Fride, E., Mechoulam, R., 1993. Pharmacological activity of the cannabinoid agonist anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313-314.
11. Howlett, A., 1995. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
12. Lee, M., Yang, K.H., Kaminski, N.E., 1995. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275, 529-536.
13. Martin, B.R., Compton, D.R., Thomas, B.F., Prescot, W.R., Little, P.J., Razdan, R.K., Johnson, M.R., Melvin, L.S., Mechoulam, R., Ward, S.J., 1991. Behavioral, biochemical and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40, 471-478.
14. Maurelli, S., Bisogno, T., De Petrocellis, L., Di Luccia, A., Marino, G., Di Marzo, V., 1995. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma anandamide amidohydrolase. FEBS Lett. 377, 82-86.
15. Mechoulam, R., Ben-Shabat, S., Hanuš, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J., Vogel, Z., 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
16. Mechoulam, R., Fride, E., Hanuš, L., Sheskin, T., Bisogno, T., Di Marzo, V., Bayewitch, M., Vogel, Z., 1997. Anandamide may mediate sleep induction. Nature 389, 25-26.
17. Munro, S., Thomas, K.L., Abu-Shaar, M., 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
18. Okuyama, H., Kobayshi, Watanabe, S., 1997. Dietary fatty acids - the n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog. Lipid Res. 35, 409-457.
19. Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., Mechoulam, R., 1997. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylyl cyclase. J. Med. Chem. 40, 3228-3233.
20. Stella, N., Schweitzer, P., Piomelli, D., 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
21. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K., 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor in the brain. Biochem. Biophys. Res. Commun. 215, 89-97.